Work

The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab

Year: 2015

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-14-3040

Authors: Raymond Y. Huang, Rifaquat Rahman, Karla V. Ballman, Sara J. Felten, S. Keith Anderson, Benjamin M. Ellingson, Lakshmi Nayak, Eudocia Q. Lee, Lauren E. Abrey, Evanthia Galanis, David A. Reardon, Whitney B. Pope, Timothy F. Cloughesy, Patrick Y. Wen

Institutions: Brigham and Women's Hospital, Center for Neuro-Oncology, Dana-Farber Brigham Cancer Center, Mayo Clinic, University of California, Los Angeles, F. Hoffmann-La Roche AG

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2129366802

FWCI: 4.892

Cites: 30

Cited by: 74

Related to: 10